Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
| Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study (Bone Marrow Transplantation, (2019), 54, 3, (465-468), 10.1038/s41409-018-0294-2) | 2020 |
|
Dr Michal Sieniawski
Dr Katrina Wood
Dr Anne Lennard
| High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study | 2019 |
|
Dr Michal Sieniawski
Dr Anne Lennard
| A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma | 2015 |
|
Dr Rachel Crossland
Dr Tryfonia Mainou-Fowler
Dr Michal Sieniawski
Dr Christopher Bacon
Dr Vikki Rand
| High BACH2 gene Expression Is an Indicator of Poor Prognosis in Adult Diffuse Large B-Cell Lymphoma Treated with R-CHOP | 2014 |
|
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
| Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients | 2014 |
|
Dr Rachel Crossland
Dr Michal Sieniawski
Parimala Saminathan
Dr Tryfonia Mainou-Fowler
| MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies | 2013 |
|
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Paul Milne
et al. | Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients | 2013 |
|
Dr Michal Sieniawski
Dr Anne Lennard
| Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Clinical Features, and Current Treatment Strategies | 2011 |
|
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Dr Susan Proctor
Kate McCabe
et al. | Mature microRNAs of the miR-17-92 cluster predict for disease outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with CHOP-R immunochemotherapy | 2011 |
|
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
| Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation | 2010 |
|
Dr Michal Sieniawski
| Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: A report from the German Hodgkin Study Group (GHSG) | 2010 |
|
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al. | The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control | 2010 |
|
Dr Michal Sieniawski
Dr Malcolm Farrow
Elaine Zhao
Dr Jennifer Wilkinson
Dr Tryfonia Mainou-Fowler
et al. | A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction Of Outcome | 2009 |
|
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
| Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens | 2009 |
|
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Michal Sieniawski
| Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future | 2009 |
|
